Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2021
Course Directors:Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., and Dan G. Duda, D.M.D., Ph.D.
![]() | In collaboration with the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO) |
Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-pancreatico-biliary cancers. Through didactic lectures, case presentations, panel discussions and Q&A, faculty present information that learners can immediately implement into daily clinical practice. Topics include the importance of early diagnosis and treatment considerations, including surgery, radiation, locoregional approaches, and systemic therapies. Attendees have ample opportunity to connect and interact with peers and faculty.
Learning Objectives
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

All travel and lodging expenses are the sole responsibility of the individual registrant.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Notify me when registration opens for this course
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.